Stay updated on Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is displayed, replacing Revision: v3.3.1. No substantive study details or page content were changed.
    Difference
    0.0%
    Check dated 2025-12-01T18:00:06.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Publications section updated to note that entries are automatically filled from PubMed and may not be about the study, and the revision is updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:50:43.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Notice about government funding lapse and potential delays was removed from the page.
    Difference
    0.3%
    Check dated 2025-11-17T07:11:36.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting and layout adjustments with no changes to study content or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:46.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Updated page version to v3.2.0 and added a government-operating-status notice; removed several specific disease entries from the content.
    Difference
    3%
    Check dated 2025-10-05T10:20:01.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Updated capitalization of lymphoma names and bumped version from v3.0.2 to v3.1.0; no substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-28T03:18:36.000Z thumbnail image

Stay in the know with updates to Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.